|
|
Volumn 516, Issue 7530, 2014, Pages 156-
|
|
T-cell therapy extends cancer survival to years
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CD19 ANTIGEN;
ADOPTIVE TRANSFER;
ANIMAL;
CLINICAL TRIAL (TOPIC);
DRUG INDUSTRY;
GENETIC ENGINEERING;
GENETICS;
HUMAN;
IMMUNOLOGY;
LEUKEMIA;
LYMPHOMA;
METABOLISM;
MOUSE;
SURVIVAL RATE;
T LYMPHOCYTE;
TRANSPLANTATION;
ADOPTIVE TRANSFER;
ANIMALS;
ANTIGENS, CD19;
CLINICAL TRIALS AS TOPIC;
DRUG INDUSTRY;
GENETIC ENGINEERING;
HUMANS;
LEUKEMIA;
LYMPHOMA;
MICE;
SURVIVAL RATE;
T-LYMPHOCYTES;
|
|
EID: 84922481474
PISSN: None
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/516156a Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|